GE HealthCare Technologies Cost of Goods Sold 2020-2025 | GEHC
GE HealthCare Technologies annual/quarterly cost of goods sold history and growth rate from 2020 to 2025. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- GE HealthCare Technologies cost of goods sold for the quarter ending March 31, 2025 was $2.765B, a 0.58% increase year-over-year.
- GE HealthCare Technologies cost of goods sold for the twelve months ending March 31, 2025 was $11.483B, a 0.69% decline year-over-year.
- GE HealthCare Technologies annual cost of goods sold for 2024 was $11.467B, a 1.4% decline from 2023.
- GE HealthCare Technologies annual cost of goods sold for 2023 was $11.63B, a 4.19% increase from 2022.
- GE HealthCare Technologies annual cost of goods sold for 2022 was $11.162B, a 7.21% increase from 2021.
| GE HealthCare Technologies Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024 | $11,467 |
| 2023 | $11,630 |
| 2022 | $11,162 |
| 2021 | $10,411 |
| 2020 | $10,397 |
| 2019 | $10,085 |
| GE HealthCare Technologies Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2025-03-31 | $2,765 |
| 2024-12-31 | $3,043 |
| 2024-09-30 | $2,838 |
| 2024-06-30 | $2,837 |
| 2024-03-31 | $2,749 |
| 2023-12-31 | $3,050 |
| 2023-09-30 | $2,887 |
| 2023-06-30 | $2,877 |
| 2023-03-31 | $2,816 |
| 2022-12-31 | $3,006 |
| 2022-09-30 | $2,803 |
| 2022-06-30 | $2,688 |
| 2022-03-31 | $2,665 |
| 2021-12-31 | |
| 2021-09-30 | |
| 2020-12-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $33.311B | $19.672B |
| Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $239.054B | 28.75 |
| Boston Scientific (BSX) | United States | $154.291B | 38.63 |
| Stryker (SYK) | United States | $149.710B | 31.30 |
| EssilorLuxottica (ESLOY) | France | $128.407B | 0.00 |
| Medtronic (MDT) | Ireland | $110.260B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.622B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.216B | 26.92 |
| ResMed (RMD) | United States | $37.817B | 28.40 |
| Agilent Technologies (A) | United States | $33.696B | 21.97 |
| Terumo (TRUMY) | Japan | $27.198B | 35.33 |
| Koninklijke Philips (PHG) | Netherlands | $23.033B | 16.16 |
| Insulet (PODD) | United States | $21.551B | 84.59 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.358B | 11.79 |
| Baxter (BAX) | United States | $15.708B | 11.73 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.095B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.558B | 22.82 |
| Lantheus Holdings (LNTH) | United States | $5.573B | 14.06 |
| Prestige Consumer Healthcare (PBH) | United States | $4.039B | 18.04 |
| Perrigo (PRGO) | Ireland | $3.660B | 9.28 |
| Haemonetics (HAE) | United States | $3.526B | 16.06 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.280B | 27.25 |
| ICU Medical (ICUI) | United States | $3.251B | 23.97 |
| GN Store Nord (GNNDY) | Denmark | $2.346B | 19.43 |
| LeMaitre Vascular (LMAT) | United States | $1.910B | 42.70 |
| QuidelOrtho (QDEL) | United States | $1.901B | 13.07 |
| AtriCure (ATRC) | United States | $1.598B | 0.00 |
| Acuren (TIC) | United States | $1.263B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.216B | 12.34 |
| Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
| Neogen (NEOG) | United States | $1.057B | 13.53 |
| BioLife Solutions (BLFS) | United States | $1.015B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.003B | 12.82 |
| Kestra Medical Technologies (KMTS) | United States | $0.908B | 0.00 |
| InMode (INMD) | Israel | $0.898B | 9.05 |
| CeriBell (CBLL) | United States | $0.698B | 0.00 |
| Owens & Minor (OMI) | United States | $0.607B | 5.04 |
| Evolus (EOLS) | United States | $0.587B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.578B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.557B | 0.00 |
| Valneva SE (VALN) | France | $0.468B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.459B | 0.00 |
| Surmodics (SRDX) | United States | $0.413B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.396B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.335B | 12.32 |
| SNDL (SNDL) | Canada | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 23.27 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.250B | 0.00 |
| ZimVie (ZIMV) | United States | $0.250B | 11.34 |
| Sanara MedTech (SMTI) | United States | $0.249B | 0.00 |
| Quanterix (QTRX) | United States | $0.241B | 0.00 |
| Brainsway (BWAY) | Israel | $0.233B | 61.65 |
| Biote (BTMD) | United States | $0.227B | 6.37 |
| Canopy Growth (CGC) | Canada | $0.226B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.220B | 65.33 |
| OraSure Technologies (OSUR) | United States | $0.215B | 0.00 |
| Omeros (OMER) | United States | $0.205B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.197B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.181B | 14.71 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.144B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.81 |
| Jin Medical (ZJYL) | China | $0.108B | 0.00 |
| Veru (VERU) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.32 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.078B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
| Zynex (ZYXI) | United States | $0.074B | 0.00 |
| Apyx Medical (APYX) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.063B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 59.98 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.25 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |